1. Bell, D. A., Thompson, C. L., Taylor J., Miller, C. R, Perera, Hsieh, F. L. L., and Lucier, G. W., 1992,Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application toglutathione transferase µ, Env Health Perspect. 98: 113.
2. Bock, K. W., Wiltfang, J., Blume, R, Ullrich, D., and Bircher, J., 1987, Paracetamol as a test drug todetermine glucuronide formation in man. Effects of inducers and of smoking, Eur J Clin Pharmacol. 31: 677.
3. Bock, K. W., 1991, Roles of UDP-glucuronosyltransferases in chemical carcinogenesis, Crit Rev Biochem Molec Biol. 26 (2): 129.
4. Doostdar, H., Duthie S. J., Gray, A. G., Burke M. D., 1988, The influence of culture medium composition on drug metabolizing enzyme activities of the human liver-derived Hep-G2 hepatoma cell line, FEBS Lett. 241:15.
5. Gerhäuser, C., You, M., Liu, Jinfang, Moriarty, R. M., Hawthorne, M., Mehta, R. G., Moon, R. C., and Pezzuto J. M., 1997, Cancer chemopreventive potential of sulforamate, an novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes, Cancer Res. 57:272.